ESC Premium Access

Sex differences in admission rates, use of anticoagulation, and outcomes for emergency department presentations of atrial fibrillation

Congress Presentation

About the speaker

Mr Patrick Daniele

University of British Columbia, Vancouver (Canada)
0 follower

9 more presentations in this session

Stroke and bleeding in low, intermediate and high risk patients with atrial fibrillation treated with edoxaban: Results of the ETNA-AF Europe registry

Speaker: Professor J. De Groot (Amsterdam, NL)


Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort study.

Speaker: Doctor C. Binding (Copenhagen, DK)


Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study

Speaker: Assistant Professor H. Yu (Seoul, KR)


Factors associated with inappropriate under-dosing of non-vitamin k antagonist oral anticoagulants (NOACs) by labelling criterion in patients with non-valvular atrial fibrillation in the UK

Speaker: Doctor A. Ruigomez (Madrid, ES)


New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation

Speaker: Doctor T. Nakano (Hiroshima, JP)


Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 2

Speakers: Mr P. Daniele, Professor J. De Groot, Doctor C. Binding, Assistant Professor H. Yu, Doctor A. Ruigomez...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb